Startups
MELLODDY aims to leverage the world’s largest collection of small molecules with known biochemical or cellular activity to enable more accurate predictive models and increase efficiencies in drug discovery. This project aims to enhance predictive Machine Learning models on decentralised data of 10 pharmaceutical companies, without exposing proprietary information.
EFPIA companies:
Amgen Research (Munich) GMBH, Munchen, Germany
Astellas Pharma Europe BV, Leiden, Netherlands
Astrazeneca AB, Södertälje, Sweden
Bayer Aktiengesellschaft, Leverkusen,
Germany Boehringer Ingelheim International GmbH, Ingelheim, Germany
Glaxosmithkline Research And Development LTD., Brentford, Middlesex, United Kingdom
Institut De Recherches Servier, Suresnes, France
Janssen Pharmaceutica Nv, Beerse, Belgium
Merck Kommanditgesellschaft Auf Aktien, Darmstadt, Germany
Novartis Pharma AG, Basel, Switzerland
Technology experts and universities:
Budapesti Muszaki Es Gazdasagtudomanyi Egyetem, Budapest, Hungary
Iktos, Paris, France
Katholieke Universiteit Leuven, Leuven, Belgium
Loodse GMBH, Hamburg, Germany
Nvidia Switzerland AG, Zurich, Switzerland
Owkin France, Paris, France
Substra Foundation, Nantes, France
EFPIA companies:
Amgen Research (Munich) GMBH, Munchen, Germany
Astellas Pharma Europe BV, Leiden, Netherlands
Astrazeneca AB, Södertälje, Sweden
Bayer Aktiengesellschaft, Leverkusen,
Germany Boehringer Ingelheim International GmbH, Ingelheim, Germany
Glaxosmithkline Research And Development LTD., Brentford, Middlesex, United Kingdom
Institut De Recherches Servier, Suresnes, France
Janssen Pharmaceutica Nv, Beerse, Belgium
Merck Kommanditgesellschaft Auf Aktien, Darmstadt, Germany
Novartis Pharma AG, Basel, Switzerland
Technology experts and universities:
Budapesti Muszaki Es Gazdasagtudomanyi Egyetem, Budapest, Hungary
Iktos, Paris, France
Katholieke Universiteit Leuven, Leuven, Belgium
Loodse GMBH, Hamburg, Germany
Nvidia Switzerland AG, Zurich, Switzerland
Owkin France, Paris, France
Substra Foundation, Nantes, France
Overview
Employees
51-200
Founded date
2019
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| EU-backed healthcare project rolls out platform for federated learning in drug discovery | The three-year project MELLODDY, which had received €18-million from the European Union and partnering EFPIA companies under the Innovative Medicines Initiative (IMI2), has now built a secure platform for privacy-preserving and federated le... |
Reviews 0
FAQ about MELLODDY consortium
When was MELLODDY consortium founded?
MELLODDY consortium was founded in 2019.
What has the press written about MELLODDY consortium?
Parsers VC has collected 2 articles mentioning MELLODDY consortium, among them “EU-backed healthcare project rolls out platform for federated learning in drug discovery”.
Is MELLODDY consortium still active?
Yes, MELLODDY consortium is active; its latest activity on Parsers VC dates from Feb 13, 2020.